Literature DB >> 16302087

Hepatitis C virus infection, cryoglobulinemia, and peripheral neuropathy: a case report.

A G Vigani1, A Macedo-de-Oliveira, M H P Pavan, M N Pedro, F L Gonçales.   

Abstract

Hepatitis C virus (HCV) is essentially hepatotropic but its manifestations can extend beyond the liver. It can be associated with autoimmune diseases, such as mixed cryoglobulinemia, membranoproliferative glomerulonephritis, autoimmune thyroiditis, and lymphoproliferative disorders. The mechanisms that trigger these manifestations are not completely understood. We describe a 48-year-old man with chronic HCV infection (circulating HCV RNA and moderate hepatitis as indicated by liver biopsy), cryoglobulinemia, and sensory and motor peripheral neuropathy. The diagnosis of multineuropathy was confirmed by clinical examination and electromyographic tests. A nerve biopsy revealed an inflammatory infiltrate in the perineurial space and signs of demyelination and axonal degeneration. The patient had no improvement of neurological symptoms with the use of analgesics and neuro-modulators. He was then treated with interferon-alpha (3 million units subcutaneously, 3 times per week) and ribavirin (500 mg orally, twice a day) for 48 weeks. Six months after the end of therapy, the patient had sustained viral response (negative HCV RNA) and remission of neurological symptoms, but cryoglobulins remained positive. A review of the literature on the pathogenesis and treatment of neurological manifestations associated with HCV infection is presented. This report underscores the need for a thorough evaluation of HCV-infected patients because of the possibility of extrahepatic manifestations. Antiviral treatment with interferon and ribavirin can be effective and should be considered in patients with neurological complications associated with HCV infection.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16302087     DOI: 10.1590/S0100-879X2005001200001

Source DB:  PubMed          Journal:  Braz J Med Biol Res        ISSN: 0100-879X            Impact factor:   2.590


  4 in total

1.  Acute inflammatory demyelinating polyneuropathy associated with pegylated interferon alpha 2a therapy for chronic hepatitis C virus infection.

Authors:  Vijay Khiani; Thomas Kelly; Adeel Shibli; Donald Jensen; Smruti R Mohanty
Journal:  World J Gastroenterol       Date:  2008-01-14       Impact factor: 5.742

2.  Sofosbuvir-daclatasvir improves hepatitis C virus-induced mixed cryoglobulinemia: Upper Egypt experience.

Authors:  Amro M Hassan; Heba A Osman; Hasan S Mahmoud; Mohammed H Hassan; Abdel-Kader A Hashim; Hesham H Ameen
Journal:  Infect Drug Resist       Date:  2018-06-27       Impact factor: 4.003

3.  Acute inflammatory demyelinating polyneuropathy after treatment with pegylated interferon alfa-2a in a patient with chronic hepatitis C virus infection: a case report.

Authors:  Mounia Lahbabi; Meryem Ghissassi; Faouzi Belahcen; Sidi Adil Ibrahimi; Nouredine Aqodad
Journal:  J Med Case Rep       Date:  2012-09-04

Review 4.  Hepatitis C Virus-Related Central and Peripheral Nervous System Disorders.

Authors:  Rita Moretti; Mauro Giuffrè; Nicola Merli; Paola Caruso; Stefano Di Bella; Claudio Tiribelli; Lory Saveria Crocè
Journal:  Brain Sci       Date:  2021-11-27
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.